It was observed that overexpression of miR-152 significantly sensitized the breast cancer cells to paclitaxel treatment; however, the chemotherapy sensitivity due to miR-152 overexpression was significantly reversed by overexpression of PKM2. The gene discussed is PKM; the disease is breast carcinoma.